Literature DB >> 19866390

Alzheimer's disease neuropathologic changes in semantic dementia.

Tiffany W Chow1, Arousiak Varpetian, Taryn Moss, Harry V Vinters, Stefanie Marquez, Carol Miller.   

Abstract

UNLABELLED: Neuropathologic change underlying primary progressive aphasia (PPA) most commonly includes one of the frontotemporal lobar degenerations, such as FTLD-tau or FTLD-ubiquitin. The next most frequent etiology of PPA is Alzheimer's disease (AD). We describe 5 subjects with clinical diagnoses of semantic dementia, who underwent longitudinal clinical evaluation and postmortem neuropathology examination of the central nervous system. This case series examines retrospectively which clinical parameters might have pointed to the neuropathological diagnosis of AD.
CONCLUSION: family history of late onset dementia, APOEepsilon4 status, combined features of semantic dementia and progressive non-fluent aphasia present early in illness, or generalized seizures, may indicate AD as the underlying pathology of semantic dementia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19866390      PMCID: PMC3049725          DOI: 10.1080/13554790903193174

Source DB:  PubMed          Journal:  Neurocase        ISSN: 1355-4794            Impact factor:   0.881


  27 in total

1.  Frontotemporal dementia progresses to death faster than Alzheimer disease.

Authors:  E D Roberson; J H Hesse; K D Rose; H Slama; J K Johnson; K Yaffe; M S Forman; C A Miller; J Q Trojanowski; J H Kramer; B L Miller
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

2.  Corticobasal degeneration as cause of progressive non-fluent aphasia: clinical, radiological and pathological study of an autopsy case.

Authors:  Masaki Takao; Kuniaki Tsuchiya; Masaru Mimura; Suketaka Momoshima; Hiromi Kondo; Haruhiko Akiyama; Norihiro Suzuki; Ban Mihara; Yasuyuki Takagi; Atsuo Koto
Journal:  Neuropathology       Date:  2006-12       Impact factor: 1.906

3.  Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration.

Authors:  Alison K Godbolt; Keith A Josephs; Tamas Revesz; Elizabeth K Warrington; Peter Lantos; Andrew King; Nick C Fox; Safa Al Sarraj; Janice Holton; Lisa Cipolotti; M Nadeem Khan; Martin N Rossor
Journal:  Arch Neurol       Date:  2005-07

4.  Frontotemporal lobar degeneration: demographic characteristics of 353 patients.

Authors:  Julene K Johnson; Janine Diehl; Mario F Mendez; John Neuhaus; Jill S Shapira; Mark Forman; Dennis J Chute; Erik D Roberson; Catherine Pace-Savitsky; Manuela Neumann; Tiffany W Chow; Howard J Rosen; Hans Forstl; Alexander Kurz; Bruce L Miller
Journal:  Arch Neurol       Date:  2005-06

5.  Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia.

Authors:  A R Varma; J S Snowden; J J Lloyd; P R Talbot; D M Mann; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

6.  Progressive aphasia secondary to Alzheimer disease vs FTLD pathology.

Authors:  K A Josephs; J L Whitwell; J R Duffy; W A Vanvoorst; E A Strand; W T Hu; B F Boeve; N R Graff-Radford; J E Parisi; D S Knopman; D W Dickson; C R Jack; R C Petersen
Journal:  Neurology       Date:  2008-01-01       Impact factor: 9.910

7.  Repeat and Point: differentiating semantic dementia from progressive non-fluent aphasia.

Authors:  John R Hodges; Marina Martinos; Anna M Woollams; Karalyn Patterson; Anna-Lynne R Adlam
Journal:  Cortex       Date:  2007-12-27       Impact factor: 4.027

8.  Cognition and anatomy in three variants of primary progressive aphasia.

Authors:  Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

9.  The diagnosis and course of frontotemporal dementia.

Authors:  Andrew Kertesz; Mervin Blair; Paul McMonagle; David G Munoz
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Apr-Jun       Impact factor: 2.703

10.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

View more
  6 in total

1.  What are the different initial presentations of frontotemporal dementia?

Authors:  Tiffany W Chow
Journal:  J Mol Neurosci       Date:  2011-05-27       Impact factor: 3.444

2.  Late Breaking Abstracts.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2019-07       Impact factor: 6.200

Review 3.  Posterior Associative and Cingulate Cortex Involvement of Brain Single-Photon Emission Computed Tomography (SPECT) Imaging in Semantic Dementia with Probable Alzheimer Disease Pathology: A Case Report.

Authors:  Yumi Takano; Keiko Kunitoki; Yasuko Tatewaki; Tatsushi Mutoh; Tomoko Totsune; Hideo Shimomura; Manabu Nakagawa; Hiroyuki Arai; Yasuyuki Taki
Journal:  Am J Case Rep       Date:  2018-02-12

4.  Case Report: Semantic Variant Primary Progressive Aphasia With Impaired Verbal Word Discrimination.

Authors:  Nobuko Kawakami; Ayumi Morita; Shigenori Kanno; Nanayo Ogawa; Kazuo Kakinuma; Yumiko Saito; Erena Kobayashi; Wataru Narita; Kyoko Suzuki
Journal:  Front Neurol       Date:  2022-06-16       Impact factor: 4.086

5.  Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia.

Authors:  Jonathan D Rohrer; Francesca Caso; Colin Mahoney; Maya Henry; Howard J Rosen; Gil Rabinovici; Martin N Rossor; Bruce Miller; Jason D Warren; Nick C Fox; Gerard R Ridgway; Maria Luisa Gorno-Tempini
Journal:  Brain Lang       Date:  2013-02-08       Impact factor: 2.381

6.  Amyloid deposition in semantic dementia: a positron emission tomography study.

Authors:  Eric E Brown; Ariel Graff-Guerrero; Sylvain Houle; Romina Mizrahi; Alan A Wilson; Bruce G Pollock; Benoit H Mulsant; Daniel Felsky; Aristotle N Voineskos; David F Tang-Wai; Nicolaas P L G Verhoeff; Morris Freedman; Zahinoor Ismail; Tiffany W Chow
Journal:  Int J Geriatr Psychiatry       Date:  2016-01-25       Impact factor: 3.485

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.